This Revenue Stream is Working Wonders for Community Health, But Some States Want to Take it Away


Community health care centers across the U.S. are funded by the 340B drug discount program, which requires "pharmaceutical companies to provide up-front discount pricing on certain medications to qualified private entities in exchange for having their drugs be eligible for coverage under Medicaid and Medicare Part B." Because access to the 340B revenue streams is dependent on state legislatures, however, the future of the program is unknown.

Related Stories